Your session is about to expire
← Back to Search
VR-Based Mobility Training for Low Vision (VR-IOMS Trial)
VR-IOMS Trial Summary
This trial tests the effectiveness of three Virtual Reality-based Intelligent Orientation and Mobility Specialists (VR-IOMSs) in teaching orientation and mobility (O&M) task skills to low vision patients. It will be conducted on two sites, University of Alabama at Birmingham (UAB) and Alabama Institute for Deaf and Blind (AIDB). The same protocol will be used on both sites. UAB will be the sIRB for the trial.
VR-IOMS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVR-IOMS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VR-IOMS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You need to be able to use a computer mouse or a joystick.My vision loss occurred later in life and has not changed recently.I have not received formal orientation and mobility training.I am receiving eye injections for a retinal disease.Your thinking and memory abilities are at a level that is considered normal for your education level.I can walk a few blocks and stand or sit for 30 minutes for training.My eye condition is getting worse quickly.My vision meets the required standards for specific tests.My hearing is normal or corrected to normal.I aim to improve my mobility and orientation skills.I have trouble speaking English.You have good enough eyesight to learn and perform tasks related to orientation and mobility, tested by walking in real streets.
- Group 1: Orientation and Mobility Training with VR-IOMSs
- Group 2: Orientation and Mobility Training with COMS
- Group 3: No Orientation and Mobility Training
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor presently seeking participants?
"Sadly, the trial's landing page on clinicaltrials.gov confirms that recruitment for this study is currently suspended; it was initially published December 1st 2022 and last amended October 16th 2022. But fortunately, 37 other trials are actively recruiting patients presently."
Share this study with friends
Copy Link
Messenger